Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline
出版年份 2020 全文链接
标题
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline
作者
关键词
-
出版物
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 201, Issue 9, Pages e56-e69
出版商
American Thoracic Society
发表日期
2020-04-14
DOI
10.1164/rccm.202003-0625st
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
- (2019) Steven Pascoe et al. Lancet Respiratory Medicine
- Blood eosinophils as a continuous variable in the treatment of COPD: impact on the guidelines
- (2019) Maarten van den Berge et al. Lancet Respiratory Medicine
- Long-term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in COPD Patients (SUNSET): a Randomized, Double-Blind, Triple-Dummy Clinical Trial
- (2018) Kenneth R Chapman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial
- (2018) Peter M A Calverley et al. Lancet Respiratory Medicine
- Evidence to Decision (EtD) framework provides a structured ‘roadmap’ for making GRADE guidelines recommendations
- (2018) Shelly-Anne Li et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
- (2018) Gary T Ferguson et al. Lancet Respiratory Medicine
- Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
- (2017) Jørgen Vestbo et al. LANCET
- A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease
- (2017) Anthony D'Urzo et al. RESPIRATORY MEDICINE
- Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
- (2017) Nicola A. Hanania et al. RESPIRATORY MEDICINE
- Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study
- (2017) Edward M Kerwin et al. International Journal of Chronic Obstructive Pulmonary Disease
- Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
- (2016) James F. Donohue et al. RESPIRATORY MEDICINE
- Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
- (2016) Henrik Watz et al. Lancet Respiratory Medicine
- Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease
- (2015) Salman H. Siddiqui et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease
- (2015) Donald A. Mahler et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Tiotropium and olodaterol fixed-dose combinationversusmono-components in COPD (GOLD 2–4)
- (2015) Roland Buhl et al. EUROPEAN RESPIRATORY JOURNAL
- Tiotropium + olodaterol shows clinically meaningful improvements in quality of life
- (2015) Dave Singh et al. RESPIRATORY MEDICINE
- Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
- (2015) Ian D Pavord et al. THORAX
- Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
- (2015) Steven Pascoe et al. Lancet Respiratory Medicine
- Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD
- (2014) Bartolome Celli et al. CHEST
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
- (2014) Helgo Magnussen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
- (2014) M. Reza Maleki-Yazdi et al. RESPIRATORY MEDICINE
- Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
- (2014) Dave Singh et al. BMC Pulmonary Medicine
- Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies
- (2014) Richard ZuWallack et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
- (2014) Walter Vincken et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
- (2014) Marc Decramer et al. Lancet Respiratory Medicine
- Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials
- (2014) François Maltais et al. Therapeutic Advances in Respiratory Disease
- Dual bronchodilation with QVA149versussingle bronchodilator therapy: the SHINE study
- (2013) Eric D. Bateman et al. EUROPEAN RESPIRATORY JOURNAL
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
- (2013) J.F. Donohue et al. RESPIRATORY MEDICINE
- Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
- (2013) Jadwiga A Wedzicha et al. Lancet Respiratory Medicine
- Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
- (2012) Donald A Mahler et al. THORAX
- Inhaled Fentanyl Citrate Improves Exercise Endurance During High-Intensity Constant Work Rate Cycle Exercise in Chronic Obstructive Pulmonary Disease
- (2011) Dennis Jensen et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD
- (2009) D.P. Tashkin et al. RESPIRATORY MEDICINE
- Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
- (2008) Claus Vogelmeier et al. RESPIRATORY MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now